Enhancing immunogenicity of novel multistage subunit vaccine of Mycobacterium tuberculosis using PLGA:DDA hybrid nanoparticles and MPLA : subcutaneous administration
Objective(s): A new strategy in recent studies is using effective tuberculosis (TB) subunit vaccines combined with appropriate carriers and adjuvants which have shown promising results in preclinical and clinical studies. The aim of the present study was to evaluate the PLGA:DDA hybrid nanoparticles...
Main Authors: | Farzad Khademi, Arshid Yousefi, Mohammad Derakhshan, Adel Najafi, Mohsen Tafaghodi |
---|---|
Format: | Article |
Language: | English |
Published: |
Mashhad University of Medical Sciences
2019-08-01
|
Series: | Iranian Journal of Basic Medical Sciences |
Subjects: | |
Online Access: | http://ijbms.mums.ac.ir/article_13321_066c72f5407dd8f47bd090c7d1a9a493.pdf |
Similar Items
-
MUC1 Specific Immune Responses Enhanced by Coadministration of Liposomal DDA/MPLA and Lipoglycopeptide
by: Jing-Jing Du, et al.
Published: (2022-02-01) -
Design and immunological evaluation of anti-CD205-tailored PLGA-based nanoparticulate cancer vaccine
by: Jahan ST, et al.
Published: (2018-01-01) -
Multi-stage subunit vaccines against Mycobacterium tuberculosis: an alternative to the BCG vaccine or a BCG-prime boost?
by: Farzad Khademi, et al.
Published: (2018-01-01) -
Modulation of dendritic cell metabolism by an MPLA-adjuvanted allergen product for specific immunotherapy
by: Jennifer Zimmermann, et al.
Published: (2022-08-01) -
Behaviors and Mechanism of Quartz Flotation with DDA and DTAC
by: Tingxia Wang, et al.
Published: (2023-12-01)